Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$761M |
| 3 |
Apple
AAPL
|
+$685M |
| 4 |
Amazon
AMZN
|
+$507M |
| 5 |
Cigna
CI
|
+$391M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$741M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$651M |
| 3 |
PX
Praxair Inc
PX
|
+$555M |
| 4 |
COL
Rockwell Collins
COL
|
+$293M |
| 5 |
CA
CA, Inc.
CA
|
+$178M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.64% |
| 2 | Financials | 15.19% |
| 3 | Healthcare | 14.85% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Lineage Cell Therapeutics
LCTX
$278M
| $1.12M | ﹤0.01% |
1,227,540
-132,928
| -10% | -$204K |
|
3027
Orion Group Holdings
ORN
$418M
| $1.11M | ﹤0.01% |
259,829
+12,679
| +5% | +$63.7K |
|
|
PMBC
3028
DELISTED
Pacific Mercantile Bancorp
PMBC
| $1.11M | ﹤0.01% |
155,498
+7,279
| +5% | +$58.4K |
|
3029
Clearfield
CLFD
$374M
| $1.11M | ﹤0.01% |
111,925
+5,110
| +5% | +$60.7K |
|
3030
LSB Industries
LXU
$693M
| $1.11M | ﹤0.01% |
260,978
+11,154
| +4% | +$65.5K |
|
|
PZN
3031
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $1.11M | ﹤0.01% |
128,146
+7,740
| +6% | +$75.1K |
|
3032
Mid Penn Bancorp
MPB
$952M
| $1.11M | ﹤0.01% |
48,092
+5,187
| +12% | +$133K |
|
3033
Canadian National Railway
CNI
$76.6B
| $1.1M | ﹤0.01% |
14,905
+3,237
| +28% | +$268K |
|
3034
Talphera
TLPH
$74.2M
| $1.1M | ﹤0.01% |
23,917
+6,612
| +38% | +$443K |
|
|
EIDX
3035
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $1.1M | ﹤0.01% |
80,021
+48,659
| +155% | +$614K |
|
3036
Genco Shipping & Trading
GNK
$1.1B
| $1.1M | ﹤0.01% |
139,473
-65,730
| -32% | -$669K |
|
|
ESTE
3037
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $1.1M | ﹤0.01% |
243,585
+36,482
| +18% | +$275K |
|
|
CUK
3038
DELISTED
Carnival PLC
CUK
| $1.1M | ﹤0.01% |
22,558
+11,775
| +109% | +$667K |
|
3039
Smith & Nephew
SNN
$12.6B
| $1.1M | ﹤0.01% |
29,356
+6,110
| +26% | +$220K |
|
3040
Royal Bank of Canada
RY
$293B
| $1.09M | ﹤0.01% |
15,995
-509
| -3% | -$37.2K |
|
3041
Parke Bancorp
PKBK
$405M
| $1.09M | ﹤0.01% |
64,127
+3,107
| +5% | +$55K |
|
|
SYBX
3042
DELISTED
Synlogic
SYBX
| $1.09M | ﹤0.01% |
10,344
+1,106
| +12% | +$146K |
|
|
VIA
3043
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $1.08M | ﹤0.01% |
29,229
+691
| +2% | +$28.7K |
|
3044
Royce Value Trust
RVT
$2.3B
| $1.08M | ﹤0.01% |
+91,758
| New | +$1.27M |
|
3045
Seres Therapeutics
MCRB
$48.4M
| $1.07M | ﹤0.01% |
11,889
+574
| +5% | +$80.3K |
|
3046
Tower Semiconductor
TSEM
$28.5B
| $1.07M | ﹤0.01% |
72,688
+3,417
| +5% | +$56.9K |
|
3047
Hawthorn Bancshares
HWBK
$278M
| $1.07M | ﹤0.01% |
61,900
| – | – |
|
3048
Liquidia Corp
LQDA
$8.02B
| $1.07M | ﹤0.01% |
49,319
+16,453
| +50% | +$385K |
|
|
EIGR
3049
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.06M | ﹤0.01% |
3,493
+904
| +35% | +$292K |
|
|
BXG
3050
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
| $1.06M | ﹤0.01% |
82,197
+10,591
| +15% | +$143K |
|
Similar funds
Geode Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Geode Capital Management held 4,266 positions worth $323B, down 8.8% from $355B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Geode Capital Management deployed $21.9B of net new capital in Q4 2018, opening 149 new positions and adding to 3,108 existing holdings. Its largest new stake was Linde: 6,406,340 shares worth $998M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dell, an estimated $92.5M trimmed.
- Geode Capital Management's largest Q4 2018 buy was Linde: 6,406,340 shares worth $998M.
- Geode Capital Management added most to Microsoft in Q4 2018, an estimated $761M increase.
- Geode Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $92.5M.
- Geode Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $741M.
- Geode Capital Management's ten largest holdings make up 17% of its $323B portfolio in Q4 2018.
- Geode Capital Management opened 149 new positions and closed 120 in Q4 2018.
- Geode Capital Management's portfolio value fell 8.8% quarter-over-quarter to $323B.
Based on Geode Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.